Astragaloside-IV induces the differentiation of bone marrow mesenchymal stem cells into osteoblasts through NMUR2-mediated Wnt/β-catenin pathway

Regen Med. 2023 Jun;18(6):471-485. doi: 10.2217/rme-2022-0184. Epub 2023 May 31.

Abstract

Aim: Given that astragaloside-IV (As-IV) has the ability to promote osteogenic differentiation, its mechanism is worthy of exploration. Methods: The effect of As-IV on rat tibial defects was examined by histopathological staining and MiR-CT scan. The alkaline phosphatase (ALP) content, osteogenic differentiation-related gene expressions, and mineralized nodule formation in bone marrow mesenchymal stem cells (BMSCs) were detected. Results: As-IV repaired tibial defects of rats. As-IV or neuromedin receptor 2 (NMUR2) overexpression elevated ALP content, mineralized nodules, osteogenic differentiation-related genes, β-catenin and NMUR2 levels, the effects of which were reversed by NMUR2 silencing or Wnt/β-catenin pathway inhibitors. Conclusion: As-IV regulates the Wnt/β-catenin pathway through NMUR2 to promote the repair of tibial defects in rats and the differentiation of BMSCs into osteoblasts.

Keywords: Wnt/β-catenin pathway; astragaloside-IV; bone marrow mesenchymal stem cells; neuromedin receptor 2; tibia defect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism
  • Cell Differentiation
  • Cells, Cultured
  • Mesenchymal Stem Cells*
  • Osteoblasts
  • Osteogenesis
  • Rats
  • Wnt Signaling Pathway / genetics
  • beta Catenin*

Substances

  • beta Catenin
  • astragaloside A